3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Nervous System Disorders in 2 studies
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawai, M | 1 |
| Horikawa, Y | 1 |
| Ishihara, T | 1 |
| Shimamoto, K | 1 |
| Ohfune, Y | 1 |
| Madsen, U | 1 |
| Ferkany, JW | 1 |
| Jones, BE | 1 |
| Ebert, B | 1 |
| Johansen, TN | 1 |
| Holm, T | 1 |
| Krogsgaard-Larsen, P | 1 |
2 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Nervous System Disorders
| Article | Year |
|---|---|
2-(Carboxycyclopropyl)glycines: binding, neurotoxicity and induction of intracellular free Ca2+ increase.
Topics: Amino Acids, Dicarboxylic; Animals; Aspartic Acid; Binding, Competitive; Brain Chemistry; Calcium; C | 1992 |
NMDA receptor agonists derived from ibotenic acid. Preparation, neuroexcitation and neurotoxicity.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cerebral Cortex; Choline O-Acetyl | 1990 |